Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the recombinant shingles vaccine (Shingrix) -- were tied to a lower dementia risk ...

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...

The UK’s drugs regulator has advised healthcare professionals to alert RSV vaccine recipients to Guillain-Barré syndrome symptoms, although the risk remains low.

British regulators issued the alert for two versions of a jab given to millions of pensioners and pregnant women after reports of patients developing a rare neurological disorder.

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines.

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting against dementia.

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of developing dementia within 18 months compared to flu vaccine recipients ...

Protection against painful shingles isn't the only reason to get vaccinated. New research shows the shot could also shield your heart for up to eight years, especially if you're under 60.

A Texas boy needed protection from measles. The vaccine cost $1,400. A family living in Galveston was surprised to be charged thousands of dollars for immunizations for their children.